Adenosine Metabolism in the Cerebral Cortex from Several Mice Models during Aging
Open Access
- 2 October 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (19) , 7300
Abstract
Adenosine is a neuromodulator that has been involved in aging and neurodegenerative diseases as Alzheimer’s disease (AD). In the present work, we analyzed the possible modulation of purine metabolites, 5’nucleotidase (5′NT) and adenosine deaminase (ADA) activities, and adenosine monophosphate (AMP)-activated protein kinase (AMPK) and its phosphorylated form during aging in the cerebral cortex. Three murine models were used: senescence-accelerated mouse-resistant 1 (SAMR1, normal senescence), senescence-accelerated mouse-prone 8 (SAMP8, a model of AD), and the wild-type C57BL/6J (model of aging) mice strains. Glutamate and excitatory amino acid transporter 2 (EAAT2) levels were also measured in these animals. HPLC, Western blotting, and enzymatic activity evaluation were performed to this aim. 5′-Nucleotidase (5′NT) activity was decreased at six months and recovered at 12 months in SAMP8 while opposite effects were observed in SAMR1 at the same age, and no changes in C57BL/6J mice. ADA activity significantly decreased from 3 to 12 months in the SAMR1 mice strain, while a significant decrease from 6 to 12 months was observed in the SAMP8 mice strain. Regarding purine metabolites, xanthine and guanosine levels were increased at six months in SAMR1 without significant differences in SAMP8 mice. In C57BL/6J mice, inosine and xanthine were increased, while adenosine decreased, from 4 to 24 months. The AMPK level was decreased at six months in SAMP8 without significant changes nor in SAMR1 or C57BL/6J strains. Glutamate and EAAT2 levels were also modulated during aging. Our data show a different modulation of adenosine metabolism participants in the cerebral cortex of these animal models. Interestingly, the main differences between SAMR1 and SAMP8 mice were found at six months of age, SAMP8 being the most affected strain. As SAMP8 is an AD model, results suggest that adenosinergic metabolism is involved in the neurodegeneration of AD.Keywords
Funding Information
- Ministerio de Ciencia, Innovación y Universidades (PID2019-109206GB-I00, SAF2016-33307)
- Junta de Comunidades de Castilla-La Mancha (SBPLY/19/180501/000251, PRE-8002/2014)
- Universidad de Castilla-La Mancha (2020-GRIN-29108)
This publication has 103 references indexed in Scilit:
- Cellular function and molecular structure of ecto-nucleotidasesPurinergic Signalling, 2012
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Age-related changes in AMP-activated protein kinase after strokeAGE, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathiesActa Neuropathologica, 2010
- Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levelsAging Cell, 2009
- Comparative Evaluation of Adenosine Deaminase Activity in Cerebral Cortex and Hippocampus of Young and Adult Rats: Effect of Garlic Extract (Allium sativum L.) on Their Susceptibility to Heavy Metal ExposureBasic & Clinical Pharmacology & Toxicology, 2009
- Dysfunction of astrocytes in senescence‐accelerated mice SAMP8 reduces their neuroprotective capacityAging Cell, 2008
- Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber SynapsesNeuron, 2008
- Modification of A-i and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the ratNeuroReport, 1995